Key Points

  • TD Cowen raised Everpure’s price target to $170 from $100 following a second hyperscaler win for its DirectFlash storage technology.
  • Everpure combines approximately $1.05 billion in quarterly revenue with gross margins above 70% and $111.8 million in free cash flow.
  • The company’s premium valuation makes continued AI-driven growth and hyperscaler adoption critical to supporting investor expectations.
hero

AI Storage Momentum Puts Everpure in the Spotlight

Everpure Inc. has emerged as a notable beneficiary of the artificial intelligence infrastructure spending cycle, with its shares rising about 5.05% amid a series of bullish developments. The latest catalyst is TD Cowen’s decision to raise its price target from $100 to $170 following a second hyperscaler win involving the company’s DirectFlash storage technology. The move reinforces a broader market narrative that demand for high-performance storage is becoming an increasingly important component of AI data-center investment.

The stock has already demonstrated substantial momentum, climbing from roughly $76 on August 3 to around $108 on August 26. That rapid appreciation reflects growing investor expectations rather than simply current earnings performance, putting greater emphasis on future hyperscaler adoption and the company’s ability to convert AI-related demand into sustained revenue growth.

Hyperscaler Contracts Strengthen the DirectFlash Story

The most important development is the expansion of Everpure’s customer base among major cloud and technology companies. The company already has business with Meta, while the latest hyperscaler win is believed to involve Oracle. Two major customers adopting the same storage technology potentially changes the market perception of DirectFlash from a promising product into a solution with broader enterprise and hyperscaler applicability.

That distinction matters because AI workloads require increasingly sophisticated storage infrastructure capable of supporting large-scale data processing. TD Cowen’s $170 target represents a significant increase from its previous $100 objective, suggesting analysts see greater potential for Everpure to participate in the expansion of AI infrastructure spending. Morgan Stanley has also upgraded the company to overweight, highlighting its combination of AI exposure, market-share opportunities and leverage to the current hardware cycle.

Strong Cash Generation Meets a Demanding Valuation

Everpure’s operating figures provide additional support for the bullish narrative. The company recently reported approximately $1.05 billion in quarterly revenue and gross margins above 70%. Free cash flow reached about $111.8 million, while net income was approximately $24.1 million. The combination of high gross margins and solid cash generation gives Everpure financial flexibility as demand for AI-related infrastructure develops.

However, the valuation reflects considerable optimism. A price-to-earnings ratio near 346 and price-to-sales ratio above 8 indicate that investors are already paying a substantial premium for future growth. This creates an asymmetric trading environment: additional hyperscaler wins or stronger-than-expected results could support further momentum, but disappointing guidance could trigger a sharp repricing.

Outlook

Everpure enters its next earnings catalyst with expectations already elevated. Morgan Stanley reportedly anticipates revenue and earnings per share could exceed expectations but prefers waiting for a potential post-earnings pullback before adding exposure, particularly ahead of the company’s analyst day in late September. Investors will therefore be watching not only the headline results but also evidence that DirectFlash adoption is expanding beyond individual customer wins. The central question is whether Everpure can turn the current AI infrastructure enthusiasm into a durable hyperscaler franchise without allowing its premium valuation to become a vulnerability.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | RTX’s Raytheon Secures Missile Defense Contract Worth Up to $6.3 Billion
    • Ronny Mor
    • •
    • 6 Min Read
    • •
    • ago 16 minutes

    SKN | RTX’s Raytheon Secures Missile Defense Contract Worth Up to $6.3 Billion SKN | RTX’s Raytheon Secures Missile Defense Contract Worth Up to $6.3 Billion

    RTX’s Raytheon has secured a U.S. military contract valued at up to $6.3 billion, adding another major award to a

    • ago 16 minutes
    • •
    • 6 Min Read

    RTX’s Raytheon has secured a U.S. military contract valued at up to $6.3 billion, adding another major award to a

    SKN | Could Oracle’s Rising Debt and AI Infrastructure Spending Put Its Growth Strategy Under Pressure?
    • Ronny Mor
    • •
    • 7 Min Read
    • •
    • ago 5 hours

    SKN | Could Oracle’s Rising Debt and AI Infrastructure Spending Put Its Growth Strategy Under Pressure? SKN | Could Oracle’s Rising Debt and AI Infrastructure Spending Put Its Growth Strategy Under Pressure?

    Oracle shares came under significant pressure Thursday as investors assessed the growing financial requirements behind the company’s artificial intelligence infrastructure

    • ago 5 hours
    • •
    • 7 Min Read

    Oracle shares came under significant pressure Thursday as investors assessed the growing financial requirements behind the company’s artificial intelligence infrastructure

    SKN | Moderna and Eli Lilly Lead Healthcare Stocks Higher as Markets Retreat
    • Ronny Mor
    • •
    • 6 Min Read
    • •
    • ago 24 hours

    SKN | Moderna and Eli Lilly Lead Healthcare Stocks Higher as Markets Retreat SKN | Moderna and Eli Lilly Lead Healthcare Stocks Higher as Markets Retreat

    Healthcare stocks delivered a strong performance on Wednesday, October 7, showing resilience as broader U.S. markets pulled back. Moderna gained

    • ago 24 hours
    • •
    • 6 Min Read

    Healthcare stocks delivered a strong performance on Wednesday, October 7, showing resilience as broader U.S. markets pulled back. Moderna gained

    SKN | CRWD Stock Pops: CrowdStrike Launches Fourth Cybersecurity Startup Accelerator Alongside Nvidia and Amazon
    • sagi habasov
    • •
    • 6 Min Read
    • •
    • ago 1 day

    SKN | CRWD Stock Pops: CrowdStrike Launches Fourth Cybersecurity Startup Accelerator Alongside Nvidia and Amazon SKN | CRWD Stock Pops: CrowdStrike Launches Fourth Cybersecurity Startup Accelerator Alongside Nvidia and Amazon

    Shares of cybersecurity pioneer CrowdStrike Holdings, Inc. (NASDAQ: CRWD) moved higher on Tuesday after the firm officially kicked off its

    • ago 1 day
    • •
    • 6 Min Read

    Shares of cybersecurity pioneer CrowdStrike Holdings, Inc. (NASDAQ: CRWD) moved higher on Tuesday after the firm officially kicked off its